Monday, February 22, 2016

F.D.A. Asks if Faulty Blood Monitor Tainted Xarelto Approval by KATIE THOMAS


By KATIE THOMAS

Johnson & Johnson has been asked whether Alere’s recalled INRatio blood-testing monitor compromised a trial of the anticlotting drug.

Published: February 23, 2016 at 12:00AM

from NYT Business Day http://ift.tt/1QcWNbx



from WordPress http://ift.tt/1Tw0SZa
via Hadi Aboukhater
Posted by at
Labels: , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)